What We Do
CIBMTR has a broad range of research activities, but our focus is narrow. Patients. They are the reason CIBMTR exists. Patients count on us to discover and apply the best therapies that research has identified, and to never let up in our efforts to improve those therapies.
Learn how we collaborate worldwide to help more patients.
Lead and conduct research studies
CIBMTR leads a worldwide collaboration of scientists and clinicians to advance understanding and outcomes of hematopoietic cell transplantation (HCT). This research helps assess donor safety and helps identify the most promising transplant approaches and the patients most likely to benefit from this therapy.
CIBMTR is at the forefront of both observational and prospective research in hematopoietic cell transplantation (HCT). We provide opportunities for involvement, resources and data management, and increased visibility for transplant advancements. Anyone committed to furthering the field of HCT can find meaningful ways to become involved and ample support for achieving their goals
Collect and maintain outcomes data
We collect outcomes data on every allogeneic transplantation performed in the U.S. (for the SCTOD, as required by U.S. law). (http://www.cibmtr.org/DataManagement/pages)/index.aspxU.S. transplant centers also voluntarily submit autologous transplantation data, and transplant centers worldwide voluntarily submit both autologous and allogeneic transplantation data. As a result, our clinical database now contains information on more than 350,000 transplant recipients.
As a transplant center administrator or data manager, you play a critical role in advancing hematopoietic cell transplantation through complete, accurate and timely data submission to CIBMTR. Your efforts are key in supporting the research that has led to increased survival and an enriched quality of life for thousands of patients.
Provide access to outcomes data
Collected data can be accessed for patient care decisions, developing research studies, education, transplant center administrative needs, and CIBMTR research.
CIBMTR maintains one of the world’s largest observational database of clinical information on hematopoietic cell transplantation (HCT). These data are available for clinical decision-making, for use in studies, for presentations and other research purposes.
Provide access to research repository sample
The NMDP Research Sample Repository contains more than 19,000 related and unrelated paired transplant recipient/donor (or cord blood) samples with complete, validated clinical data. Samples can be used for local research studies, or for CIBMTR research studies.
CIBMTR supports investigators engaged in retrospective analysis of immunogenetics and immunobiology in relation to hematopoietic cell transplantation outcomes through the unique resource of the National Marrow Donor Program® (NMDP) Research Sample Repository, established in 1988 and located in New Brighton, Minnesota. This repository offers investigators from a variety of disciplines access to thousands of recipient/donor (or cord blood unit) paired samples with complete, validated clinical data collected from NMDP facilitated transplants and related donor transplants from select transplant centers participating in the Stem Cell Therapeutic Outcomes Database (SCTOD).
Provide statistical expertise to researcher
Both new and experienced investigators have access to biostatistical support to write study proposals, and develop protocols.
Since 1985, CIBMTR has benefited from a unique, collegial partnership with the biostatisticians of the Medical College of Wisconsin (MCW). Together with our scientific directors, the biostatisticians from CIBMTR and MCW are working with investigators from around the world to explore new and better approaches for analyzing hematopoeitic cell transplantation (HCT) data.
Provide education, guidelines and training
CIBMTR provides trends, outcomes data and presentation graphics, develops post-transplant care guidelines and conducts meetings for education, science and training. The CIBMTR has published more than 700 peer-reviewed papers in the medical literature since 1972.
The CIBMTR Reference Center offers a wide range of resources for investigators, physicians and patients—from published studies and statistical data to guidelines for transplant patients and their families. This is one of the ways CIBMTR research is used to create a better understanding of transplantation.